The dose limiting toxicity ssociated with this regimen was myelo suppression with grade 3~4 neutrocytopenia in 72 % of patients.
本化疗方案的剂量限制毒性为骨髓抑制，其中72 %的病人发生3～4度中性粒细胞下降。
The dose limiting toxicity ssociated with this regimen was myelo suppression with grade 3~4 neutrocytopenia in 72 % of patients.
本化疗方案的剂量限制毒性为骨髓抑制，其中72 %的病人发生3～4度中性粒细胞下降。
应用推荐